VAL-083

dianhydrogalactitol · Kintara Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VAL-083, covering 2025-08-29 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression [Phase 2]

See pricing